Editas Medicine (EDIT) Stock Price, Quote, News & History | Benzinga

Editas Medicine Inc (EDIT) Stock Price, Quote, News & History

EDITNASDAQ

Trade with Public

Trade with Public

$2.62

-0.23-8.07%

At close: May 15, 5:00 PM EST

$2.61

-0.0091-0.35%

After Hours: 6:10 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$2.80

Close

$2.62

Volume / Avg.

1.28M / 1.59M

Day Range

$2.57 - $2.88

52 Wk Range

1.35 - 4.54

Market Cap

$255.62M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

10.25%

Days to Cover

7.07

Recent Editas Medicine Inc News

Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles

Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event.

Akanksha Bakshi

Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst

Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.

Vandana Singh

JPMorgan Downgrades Editas Medicine, Says Focus Shift Sparks Investor Caution

Editas Medicine pivots to in vivo gene editing, extends cash runway to 2027, but faces investor caution amid unclear proof-of-concept timelines.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-140.50M

Investing Cash Flow (TTM)

82.35M

Financing Cash Flow (TTM)

41.91M

Free Cash Flow (TTM)

-141.09M

Capital Expenditure (TTM)

-585.00K

Net Change in Cash (TTM)

-16.25M

Analyst Trends and Forecast

2

Mar

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$172.68M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.81

PB Ratio (TTM)

63.30

Earnings Yield % (TTM)

-40.00%

Earnings Yield % (FWD)

-41.40%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.05

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$123.65M

Debt to Equity

3.92

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$2.80

Close

$2.62

Volume / Avg.

1.28M / 1.59M

Day Range

$2.57 - $2.88

52 Wk Range

1.35 - 4.54

Market Cap

$255.62M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

10.25%

Days to Cover

7.07

About

Sector

Health Care

Industry

Biotechnology

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform base...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Editas Medicine (EDIT) stock?

A

You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Editas Medicine (EDIT) competitors?

A

There are no as such competitors for Editas Medicine.

Q

What is the forecast, or price target, for Editas Medicine (EDIT) stock?

A

Editas Medicine has a consensus price target of $7.82.

Q

What is the current price for Editas Medicine (EDIT)?

A

The stock price for Editas Medicine (NASDAQ: EDIT) is $2.6109 last updated May 15, 2026 at 6:10 PM EDT.

Q

Does Editas Medicine (EDIT) pay a dividend?

A

There are no upcoming dividends for Editas Medicine.

Q

When is Editas Medicine (NASDAQ:EDIT) reporting earnings?

A

Editas Medicine does not have any upcoming earnings scheduled.

Q

Is Editas Medicine (EDIT) going to split?

A

There is no upcoming split for Editas Medicine.

Q

What sector and industry does Editas Medicine (EDIT) operate in?

A

Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.